Cidara Therapeutics, Inc.
CDTX
Revenue
302.00k
▼-2.52M▼-89.31%
3 Months ChangeAssets
173.36M
▲120.64M▲228.85%
3 Months ChangeLiabilities
42.42M
▼-28.08M▼-39.82%
3 Months ChangeFree Cash Flow
-6.67M
▲4.33M▲39.35%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001610618-24-000127
2024-09-12
Form 8-K
ID: 0001610618-24-000121
2024-08-13
Form 8-K
ID: 0001610618-24-000117
2024-08-13
Form 10-Q
ID: 0001610618-24-000115
2024-07-18
Form 8-K
ID: 0001610618-24-000091
2024-05-20
Form 8-K
ID: 0001610618-24-000076
2024-05-15
Form 8-K
ID: 0001610618-24-000074
2024-05-15
Form 10-Q
ID: 0001610618-24-000073
2024-05-03
Form 8-K
ID: 0001610618-24-000068
2024-04-24
Form 8-K
ID: 0001610618-24-000051